AcuraBio partners with Cytiva to alleviate supply constraints for mRNA, cell and gene therapies

February 13, 2023 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

AcuraBio has announced that it will provide a cGMP plasmid DNA contract development and manufacturing service using Cytiva’s new process platform technology. …

Subscribe now to continue reading.

Latest Video

NSW Premier opens Australia’s first large-scale health translation hub at UNSW
November 24, 2025 - Latest News
Australia has 'all the ingredients' but has to decide what kind of health system it wants
November 26, 2025 - BioPharma
New review recommends a balanced and measured approach to adopting AI in clinical practice
November 24, 2025 - BioPharma
Sanofi becomes first tenant of ENTRI, marking major step for Queensland’s translational research ambitions
November 24, 2025 - Latest News
Cynata completes final patient visits in pivotal Phase 3 osteoarthritis trial
November 24, 2025 - Australian Biotech

AcuraBio partners with Cytiva to alleviate supply constraints for mRNA, cell and gene therapies

This is a preview of subscriber content

Latest Video

Most Read

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

Australia has 'all the ingredients' but has to decide what kind of health system it wants

New review recommends a balanced and measured approach to adopting AI in clinical practice

Sanofi becomes first tenant of ENTRI, marking major step for Queensland’s translational research ambitions

Cynata completes final patient visits in pivotal Phase 3 osteoarthritis trial

New Stories

An interview that reminds us of the missing discussion in Australia

Neurizon Therapeutics entering 'a promising new horizon” as ALS program advances

Slade Pharmacy marks anniversary with record research contributions at conferences

US secures significant price reductions on 15 medicines in second round of medicare negotiations

The US and UK edging closer to an agreement on pharmaceutical pricing

US Medicare sets reimbursement price for PromarkerD, paving way for major commercial rollout

Recce reports strong preclinical efficacy for inhaled R327 in hospital-acquired pneumonia model

Sign In

AcuraBio partners with Cytiva to alleviate supply constraints for mRNA, cell and gene therapies

This is a preview of subscriber content

Latest Video

Most Read

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

Australia has 'all the ingredients' but has to decide what kind of health system it wants

New review recommends a balanced and measured approach to adopting AI in clinical practice

Sanofi becomes first tenant of ENTRI, marking major step for Queensland’s translational research ambitions

Cynata completes final patient visits in pivotal Phase 3 osteoarthritis trial

Follow Us

New Stories

An interview that reminds us of the missing discussion in Australia

Neurizon Therapeutics entering 'a promising new horizon” as ALS program advances

Slade Pharmacy marks anniversary with record research contributions at conferences

US secures significant price reductions on 15 medicines in second round of medicare negotiations

The US and UK edging closer to an agreement on pharmaceutical pricing

US Medicare sets reimbursement price for PromarkerD, paving way for major commercial rollout

Recce reports strong preclinical efficacy for inhaled R327 in hospital-acquired pneumonia model